GOLIKE

GOLIKE is a next-generation medical food product engineered with proprietary Physiomimic technology for the dietary management of phenylketonuria (PKU) and other metabolic genetics disorders such as tyrosinemia and homocystinuria. Developed by APR Applied Pharma Research (a subsidiary of Relief Therapeutics), the technology allows for the prolonged release of amino acids, which helps mask the characteristic unpleasant taste and odor of amino acids and supports a more physiological absorption profile. In the United States, Eton Pharmaceuticals holds the exclusive license for the GOLIKE family of products, which are marketed as prescription medical formulas to improve patient access and adherence in the management of rare metabolic diseases.

Brand names

GOLIKEPKU GOLIKETYR GOLIKE

Other names

Physiomimic technology amino acids